- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04567121
Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)
Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)-a Randomized, Controlled Trial in Communities Following up for 50 Years
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular and cerebrovascular diseases, diabetes, chronic obstructive pulmonary disease and malignant tumors are the main chronic diseases, which have been the most important cause of human death, consuming most health resources. In China, patients with cardiovascular and cerebrovascular diseases account for more than 40% of all causes of death. After half a century of research, we have a thorough understanding of risk factors of cardiovascular disease, including genetics, aging, ethnicity, physical activity decreases, unbalanced nutrition and calorie intake, smoking, obesity, hypertension, dyslipidemia, and glucose abnormalities, etc. Many factors can be corrected through health education, indicating that the occurrence of chronic diseases can be prevented through lifestyle changes and the control of risk factors.
This project collects risk factors of cardiovascular disease and establishes a real and reliable health database by conducting a cross-sectional survey of chronic diseases among residents of Tian Tong Yuan District (there are hundreds of thousands of people).On this basis, community health management network was established with internet technology. Meanwhile, prospective, open, community randomized and controlled lifestyle intervention studies were carried out. Intervention was conducted on risk factors of cardiovascular and cerebrovascular diseases, such as smoking, obesity, hypertension, lipid metabolism disorder, and hyperglycemia. For patients with chronic diseases, lifestyle intervention and health education should be carried out to improve the diagnosis rate and control rate. The project focuses on the impact of lifestyle interventions and health education on risk factor control, cardiovascular and cerebrovascular complications, diabetes and all-cause death.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: jianzhong xiao, PHD
- Phone Number: +8613683685711
- Email: xiaojzh858@sina.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, Beijing, BJ 10
- Recruiting
- Beijing Tsinghua Changgung Hospital
-
Contact:
- zhaoxiang liu, MD
- Phone Number: +8613718898419
- Email: lzxa01684@btch.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women older than 25 years of age with two or more risk factors as follows, BMI≥24 or BMI≤18.5 kg/m2, smoking, active exercise less than 30 minutes every day, blood pressure higher than 130/85 mmHg, dyslipidemia, fasting glucose higher than 6.1mmol/l, fatty liver.
- Patients with hypertension, diabetes and ASCVD
Exclusion Criteria:
- Patients had not signed the consent form
- Patients with severe heart failure, hepatic failure, renal failure and malignant tumor.
- Patients planing pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intensive intervention group
intensive life-style and care intervention
|
Establish a team of chronic disease prevention managers (5 people), with each educator responsible for the intervention of 200 people.
For sub-health population and chronic disease patients, there would be conducted health education interview twice, 4 calls, online communication 50 times once a year, controlling risk factors and making treatment plan.
|
Other: Standard intervention group
standard life-style and care intervention
|
Conduct general health education without active management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence rate of new noncommunicable diseases
Time Frame: 2 year
|
incidence rate of new noncommunicable diseases, for example, ASCVD, diabetes mellitus, hypertension
|
2 year
|
incidence rate of major adverse cardiovascular events
Time Frame: 2 years
|
incidence rate of major adverse cardiovascular events, including nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death
|
2 years
|
incidence rate of all-cause mortality
Time Frame: 2 years
|
incidence rate of all-cause mortality in the population
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
score of quality of life (SF-36 scale)
Time Frame: 2 years
|
the improvement of quality of life
|
2 years
|
Reduce the economic burden on health
Time Frame: 2 years
|
survey of health economic burden, calculate medical expenses
|
2 years
|
Collaborators and Investigators
Investigators
- Study Director: jianzhong xiao, PHD, Beijing Tsinghua Changgeng Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20281-0-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lifestyle Intervention
-
University of Vic - Central University of CataloniaUniversity of Leeds; University of the Basque Country (UPV/EHU); The University... and other collaboratorsCompletedQuality of Life | Sedentary Lifestyle | Intervention Study | WorkplaceSpain
-
University of Turin, ItalyCompletedLifestyle Intervention
-
Icahn School of Medicine at Mount SinaiAmerican Heart AssociationCompletedAtherosclerosis | Lifestyle Intervention | Promoting Cardiovascular Health in AdultsUnited States
-
KK Women's and Children's HospitalRonald McDonald House Charities SingaporeCompletedAdolescent Obesity | Lifestyle Intervention
-
Dexa Medica GroupWithdrawnDiabetic Patients | Low HDL-cholesterol (< 35 mg/dL) | Lifestyle Intervention for at Least 1 MonthIndonesia
-
Eindhoven University of TechnologyCompletedLifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryBelgium
-
The Catholic University of KoreaMinistry for Health Welfare and Family AffairsCompletedType 2 Diabetes | Lifestyle Intervention | Glucose Control | Internet CommunicationKorea, Republic of
-
The University of Tennessee, KnoxvilleCompletedActive Lifestyle Males | Inactive Lifestyle MalesUnited States
-
Université de SherbrookeEnrolling by invitationObesity, Childhood | Lifestyle Intervention | Preconception CareCanada
-
University of HaifaCompletedPsychological Intervention | Internet-Based Intervention | Intervention StudyIsrael
Clinical Trials on Intensive intervention group
-
Adaliene Versiani M. FerreiraConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundacion MAPFRERecruiting
-
Université de SherbrookeEli Lilly and Company; Sanofi; Merck Sharp & Dohme LLC; Novartis; Amgen; Procter and... and other collaboratorsCompletedOsteoporosis | FracturesCanada
-
National Council of Scientific and Technical Research...Illumina, Inc.; Facultad de Ingeniería - Universidad Austral; Instituto de Inmunología... and other collaboratorsRecruitingObesity | Diabetes Mellitus, Type 2 | PreDiabetesArgentina
-
University of NebraskaCompletedSmoking Cessation | Substance Use DisorderUnited States
-
Third Affiliated Hospital of Zhengzhou UniversityNot yet recruitingObesity | Weight Loss | Male Fertility | IVF-ET | Artificial Insemination
-
University of California, San DiegoUniversity of Colorado, Denver; Washington University School of Medicine; University...CompletedObesity | Breast Cancer | OverweightUnited States
-
University of South CarolinaUniversidad de Costa Rica; Municipality of Alajuela; Agenda de MujeresCompleted
-
Memorial University of NewfoundlandCompletedSmoking Cessation | Quality of Life | Smoking, TobaccoCanada
-
Medical University of WarsawUniversity of Warsaw; Wola HospitalUnknownPersonality Disorders | Anxiety Disorders | Depressive DisordersPoland
-
Emory UniversityChildren's Healthcare of AtlantaCompletedFeeding and Eating Disorders | Avoidant/Restrictive Food Intake Disorder | Feeding DisordersUnited States